RT Journal Article
SR Electronic
T1 Suicide during the COVID-19 pandemic in Japan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.30.20184168
DO 10.1101/2020.08.30.20184168
A1 Tanaka, Takanao
A1 Okamoto, Shohei
YR 2020
UL http://medrxiv.org/content/early/2020/09/22/2020.08.30.20184168.abstract
AB The prolonged uncertainty of the COVID-19 pandemic, fear and anxiety regarding infections, precautionary social isolation, and the resulting economic disruption could deteriorate psychological health and exacerbate the suicidal risk. Utilizing month-level suicide records covering the entire Japanese population (126 million) in 1,861 administrative units, we assessed if suicide mortality changed during the pandemic. We employed difference-in-difference estimation and found that overall suicide rate declined by 14.8% (95% CI: −18.9% to −10.8%) after the outbreak and the subsequent measures (school closure and the state of emergency). The decline is larger among males than females and among adults than children and older adults. The government’s generous subsidies, reduced working hours, and fewer school sessions potentially account for its sizable decline.Competing Interest StatementThe authors have declared no competing interest.Funding StatementShohei Okamoto is supported by the postdoctoral fellowship of the Japan Society for the Promotion of Science (No. 20J00394) and the Murata Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was not requred as this research is based on secondary analysis of publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the paper are publicly available. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000140901.html https://github.com/sokamoto-github/Suicide-during-the-Covid-19-pandemic-in-Japan